General Management
Seven things to consider when approaching planning
Andree Bates, (Dec 10, 2009)
It’s never too early, or too late, to improve planning
The ‘value battle’: of values & value - 3
Fatima Moncrieffe, (Nov 12, 2009)
In this series, we have been exploring the areas of ‘values’ and ‘value’(see part 1 and part 2.) Here, I’d like to further explore the concept of value and next time, we’ll look at recent attempts to construct value frameworks.
How lean manufacturing can cut costs
Andrew Tolve, (Nov 11, 2009)
What the auto industry can teach the pharma sector about manufacturing efficiency.
In the eye of the beholder: Of values & value - 2
Fatima Moncrieffe, (Nov 5, 2009)
In my last article for eyeforpharma, I highlighted the very high current industry activity around the demonstration of the ‘value’ of pharma’s products, and made the point that value is rather like beauty - very much in the eye of the beholder.
Guest view: Changing the face of IT in the eyes of pharma
Kamal Biswas, (Oct 1, 2009)
It’s a no-brainer today to talk about the need for bridging Information Technology (IT) with the pharmaceutical business.
How to grow value quickly in pharma
Andree Bates, (Aug 18, 2009)
We all know the situation. The industry is facing some very major challenges, and the reality is that we as an industry should stop being all the same.
Economic crisis: time of risk or opportunity for pharma?
Lisa Roner, (Jun 3, 2009)
EFPIA, the European Federation of Pharmaceutical Industries and Associations, a group of 31 national associations and 44 pharmaceutical companies in Europe, says investing in healthcare and a strong pharmaceutical industry is a prescription for economic recovery and “a real opportunity” to bring healthcare systems into the 21st century.
Tribal territories: Of values and value- part 1
Fatima Moncrieffe, (Apr 30, 2009)
Times continue to be tough for the industry and this author has been doing some more reflection that has manifested in three linked articles.
Quick Take: Survey finds economy taking a toll on patients
Lisa Roner, (Apr 27, 2009)
An April poll by the Kaiser Family Foundation finds that “as economic conditions remain poor, a majority of the public continues to say that they or a member of their household have delayed or skipped health care in the past year."
Our view: Developing drugs that sell themselves
Lisa Roner, (Apr 2, 2009)
Everyone has ideas about what ails pharma and how it might reinvent itself to be more productive and regain the trust of the consuming public.